At least 170 million people worldwide are estimated to have diabetes mellitus, and this number is predicted to more than double by 2030. In this week's podcast Professor Colin Baigent from the Cholesterol Treatment Triallists Collaboration at the University of Oxford, UK, discusses a large meta-analysis which shows how people with diabetes can reduce their risk of cardiovascular events from statin therapy in the same way as people without diabetes, regardless of existing cardiovascular disease. He comments that in light of these results, all people with diabetes should be considered for statin treatment.